Developer docs
API playgroundTry for free, no card

Search company profiles

Hillside Hospital

Full company profile

uuid000ms19

Namestring
Hillside Hospital
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Hillside Hospital is a for-profit, privately held hospital founded in 2012 and headquartered in Pulaski, Tennessee. According to its firmographic profile, the facility provides comprehensive growth hormone therapy services and employs between 101 and 250 staff. The company's service offering is positioned around the use of "modern technology" in the delivery of hormone therapy, though specific clinical platforms, electronic health record systems, dosing protocols, or proprietary technology components are not documented in the available data. No information on facility size, bed count, service-line breadth beyond hormone therapy, or clinical outcomes is available.

As a specialty healthcare provider, Hillside Hospital's revenue model is presumed to derive from a combination of patient service fees, third-party insurance reimbursement, and out-of-pocket payments for growth hormone therapy — a therapeutic category that frequently operates on a cash-pay or self-pay basis in the US market due to limited insurance coverage for adult growth hormone deficiency treatment. No detailed pricing, payer mix, patient volume, or service-line revenue breakdown is disclosed. The company's website displayed only a loading/verification placeholder during data collection, and no information on management team, ownership structure, funding history, partnerships, accreditations, or M&A activity was accessible.

The lack of substantive data on operational metrics, competitive positioning, technology stack, and growth indicators materially limits deeper analytical conclusions. Standard investment-relevant signals — headcount trend, service expansion, clinical outcomes, payer contracts, and regulatory standing — are not documented in the input.

Short descriptiontext

Hillside Hospital is a for-profit, privately held hospital in Pulaski, Tennessee that provides comprehensive growth hormone therapy services. Founded in 2012, the facility employs 101-250 staff and serves patients requiring specialized hormone treatment using modern technology.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPulaski, United States
HQ citystring
Pulaski
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
growth hormone therapy, hospital services, endocrine treatment, hormone replacement therapy, specialty medical care
Industry2 codes
1Gender-Affirming Endocrine Care
CodeHLAKADAMPrimaryYes
2Critical Access & Rural Hospitals
CodeHLAFAAAGPrimaryNo
NAICS code2 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
  • General Medical and Surgical Hospitals62211
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Health Services8000
Product category
Hospital Services
No data
Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Hillside Hospital provides comprehensive growth hormone therapy services for patients with hormone-related medical conditions. The hospital delivers specialized endocrine care using modern medical technology and serves as a dedicated treatment facility based in Pulaski, United States.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Growth Hormone Therapy
CategoryEndocrine Care
No data
Peers10 records
TypeBroad incumbent
Description

The largest U.S. for-profit hospital operator; provides endocrinology and hormone-therapy services within a broad acute-care network and represents the dominant commercial hospital reference point.

TypeDirect peer
Description

Specialty hormone and wellness clinic with both in-person and telehealth delivery; comparable business model combining growth hormone and hormone-related therapies with tech-enabled scheduling and consultations.

TypeDirect peer
Description

Multi-location U.S. practice delivering bioidentical hormone replacement and wellness therapies — competes directly for the same cash-pay and concierge endocrinology patients.

TypeDirect peer
Description

Network of physician-owned practices offering bioidentical hormone replacement therapy and wellness services, with adjacent use of modern technology platforms — a near-direct competitor in the hormone-therapy niche.

TypeDirect peer
Description

Specialty hormone therapy provider focused on subcutaneous pellet-based hormone replacement — adjacent to growth hormone therapy and serving a similar patient demographic.

TypeBroad incumbent
Description

Large academic health system with a top endocrinology department that delivers growth hormone therapy within a much broader service portfolio — the leading incumbent benchmark for clinical credibility.

TypeDirect peer
Description

Multi-site U.S. clinic operator focused on age-management medicine and hormone optimization, including growth hormone therapy — directly overlapping with Hillside's stated specialty and patient demographic.

TypeBroad incumbent
Description

National specialty hospital with a high-volume endocrinology and metabolic institute offering growth hormone therapy as part of comprehensive care — sets the standard for clinical scale and outcomes.

9National Hormone Health Institute
TypeEmerging player
Description

Specialty hormone-therapy practice network covering growth hormone and related treatments — a comparable emerging consolidator in the cash-pay hormone-therapy segment.

TypeEmerging player
Description

Smaller specialty practice offering growth hormone and hormone-optimization services, representing a more localized/direct alternative in the same clinical niche.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hillside Hospital

Hospital Serviceshillsidehospital.com

Hillside Hospital is a for-profit, privately held hospital in Pulaski, Tennessee that provides comprehensive growth hormone therapy services. Founded in 2012, the facility employs 101-250 staff and serves patients requiring specialized hormone treatment using modern technology.

What Hillside Hospital does

Hillside Hospital is a for-profit, privately held hospital founded in 2012 and headquartered in Pulaski, Tennessee. According to its firmographic profile, the facility provides comprehensive growth hormone therapy services and employs between 101 and 250 staff. The company's service offering is positioned around the use of "modern technology" in the delivery of hormone therapy, though specific clinical platforms, electronic health record systems, dosing protocols, or proprietary technology components are not documented in the available data. No information on facility size, bed count, service-line breadth beyond hormone therapy, or clinical outcomes is available.

As a specialty healthcare provider, Hillside Hospital's revenue model is presumed to derive from a combination of patient service fees, third-party insurance reimbursement, and out-of-pocket payments for growth hormone therapy — a therapeutic category that frequently operates on a cash-pay or self-pay basis in the US market due to limited insurance coverage for adult growth hormone deficiency treatment. No detailed pricing, payer mix, patient volume, or service-line revenue breakdown is disclosed. The company's website displayed only a loading/verification placeholder during data collection, and no information on management team, ownership structure, funding history, partnerships, accreditations, or M&A activity was accessible.

The lack of substantive data on operational metrics, competitive positioning, technology stack, and growth indicators materially limits deeper analytical conclusions. Standard investment-relevant signals — headcount trend, service expansion, clinical outcomes, payer contracts, and regulatory standing — are not documented in the input.

Hillside Hospital firmographics

Firmographics
Name
Hillside Hospital
Website
https://hillsidehospital.com
Company type
Private
Founded year
2012
Headcount range
101–250 employees
Short description
Hillside Hospital is a for-profit, privately held hospital in Pulaski, Tennessee that provides comprehensive growth hormone therapy services. Founded in 2012, the facility employs 101-250 staff and serves patients requiring specialized hormone treatment using modern technology.
Ownership category
akta.pro rank

Hillside Hospital industry classification

Industry
Product category
Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), General Medical and Surgical Hospitals (62211)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)
akta.pro primary industry
Gender-Affirming Endocrine Care (HLAKADAM)
akta.pro secondary industry
Critical Access & Rural Hospitals (HLAFAAAG)

Keywords

  • Growth hormone therapy
  • Hospital services
  • Endocrine treatment
  • Hormone replacement therapy
  • Specialty medical care

Where Hillside Hospital is headquartered

Location

Headquarters

HQ city
Pulaski
HQ country
United States
HQ region
North America

Markets served

Hillside Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Hillside Hospital product offering

Product offering

Core offering

Hillside Hospital provides comprehensive growth hormone therapy services for patients with hormone-related medical conditions. The hospital delivers specialized endocrine care using modern medical technology and serves as a dedicated treatment facility based in Pulaski, United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Growth Hormone Therapy

Companies that use Hillside Hospital

Customer profile

Ideal customer profiles1 record

Hillside Hospital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Hillside Hospital competitors and assessment

Company assessment

Broad incumbents

  • HCA Healthcare: The largest U.S. for-profit hospital operator; provides endocrinology and hormone-therapy services within a broad acute-care network and represents the dominant commercial hospital reference point.
  • Mayo Clinic: Large academic health system with a top endocrinology department that delivers growth hormone therapy within a much broader service portfolio — the leading incumbent benchmark for clinical credibility.
  • Cleveland Clinic: National specialty hospital with a high-volume endocrinology and metabolic institute offering growth hormone therapy as part of comprehensive care — sets the standard for clinical scale and outcomes.

Direct peers

  • Defy Medical: Specialty hormone and wellness clinic with both in-person and telehealth delivery; comparable business model combining growth hormone and hormone-related therapies with tech-enabled scheduling and consultations.
  • Evexias Health Centers: Multi-location U.S. practice delivering bioidentical hormone replacement and wellness therapies — competes directly for the same cash-pay and concierge endocrinology patients.
  • BodyLogicMD: Network of physician-owned practices offering bioidentical hormone replacement therapy and wellness services, with adjacent use of modern technology platforms — a near-direct competitor in the hormone-therapy niche.
  • SottoPelle: Specialty hormone therapy provider focused on subcutaneous pellet-based hormone replacement — adjacent to growth hormone therapy and serving a similar patient demographic.
  • Cenegenics: Multi-site U.S. clinic operator focused on age-management medicine and hormone optimization, including growth hormone therapy — directly overlapping with Hillside's stated specialty and patient demographic.

Emerging players

  • National Hormone Health Institute: Specialty hormone-therapy practice network covering growth hormone and related treatments — a comparable emerging consolidator in the cash-pay hormone-therapy segment.
  • Fountain of Youth MD: Smaller specialty practice offering growth hormone and hormone-optimization services, representing a more localized/direct alternative in the same clinical niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Hillside Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hillside Hospital leadership team

Management profile

Number of profiles

Hillside Hospital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hillside Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hillside Hospital

What does Hillside Hospital do?

Hillside Hospital provides comprehensive growth hormone therapy services for patients with hormone-related medical conditions. The hospital delivers specialized endocrine care using modern medical technology and serves as a dedicated treatment facility based in Pulaski, United States.

When was Hillside Hospital founded?

Hillside Hospital was founded in 2012. It employs 101 to 250 people.

Where is Hillside Hospital based?

Hillside Hospital is headquartered in Pulaski, United States, in the North America region.

Who are Hillside Hospital's main competitors?

Broad incumbents on record are HCA Healthcare, Mayo Clinic and Cleveland Clinic. Direct peers are Defy Medical, Evexias Health Centers, BodyLogicMD, SottoPelle and Cenegenics. Emerging players are National Hormone Health Institute and Fountain of Youth MD.

Does Hillside Hospital have an API?

No public API is recorded for Hillside Hospital.

What industry is Hillside Hospital in?

Hillside Hospital's product category is Hospital Services. Its primary akta.pro industry code is HLAKADAM, Gender-Affirming Endocrine Care, with a secondary code of HLAFAAAG, Critical Access & Rural Hospitals. Its NAICS code is 62231 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales